[The new experimental ulcerative colitis model in rats induced by subserosal injection of acetic acid]. 2001

R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
Research Laboratories, Nisshin Kyorin Pharmaceutical Co., Ltd., 5-3-1, Tsurugaoka, Oi-machi, Iruma-gun, Saitama 356-8511, Japan.

We have developed a new experimental ulcerative colitis model in rats. Topical pathological change of a round or a ellips shape was induced by subserosal injection of acetic acid (20%, 0.02 ml) into the middle colon of rats. The size of the induced ulcer could directly be measured using a caliper gauge, and the result was expressed as the ulcer area (mm2). We determined the concentration of leukotriene B4 (LTB4), which is one of important clinical factors, in the ulcer region and found that the quantity of LTB4 was well correlated with the size of the ulcer area. Histopathological studies of the ulcer region demonstrated that there were some morphological similarities to the human form of ulcerative colitis, characterized by edema, necrosis, inflammatory cell infiltration, crypt abscess and granulation tissue formation. Effects of 5-aminosalicylic acid and sodium prednisolone phosphate were investigated by intrarectal administration in this colitis model. The predominant improvement of colitis was obtained from both treatments in the ranges of the clinical doses of each drug. In conclusion, we suggest that this colitis model provides a new way for quantitative evaluation of the efficacy of new therapeutic agents for ulcerative colitis.

UI MeSH Term Description Entries
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018836 Inflammation Mediators The endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC). Mediators of Inflammation,Mediators, Inflammation

Related Publications

R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
January 1992, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
May 2023, Biotechnic & histochemistry : official publication of the Biological Stain Commission,
R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
August 2017, The Journal of surgical research,
R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
June 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
August 2019, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
May 2021, Clinical and experimental pharmacology & physiology,
R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
January 2018, Avicenna journal of phytomedicine,
R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
April 2017, Pharmacological reports : PR,
R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
September 2013, World journal of gastroenterology,
R Kojima, and S Hamamoto, and M Moriwaki, and K Iwadate, and T Ohwaki
March 2011, European journal of pharmacology,
Copied contents to your clipboard!